{"filing":{"accession_number":"0001213900-26-070363","cik":"0001946399","ticker":"LSBWF","company_name":"LakeShore Biopharma Co., Ltd.","form":"6-K","filing_date":"2026-06-22","report_date":null,"primary_document":"ea0295413-6k_lakeshore.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1946399/000121390026070363/ea0295413-6k_lakeshore.htm"},"events":[{"id":12557,"run_id":11136,"accession_number":"0001213900-26-070363","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The press release announces the results of an extraordinary general meeting of shareholders held on June 19, 2026, where shareholders voted to approve a merger agreement between LakeShore Biopharma, Oceanpine Skyline Inc., and Oceanpine Merger Sub Inc. Approximately 92.3% of outstanding shares voted, with 86.2% of votes cast approving the merger. This is a shareholder vote result on a material transaction (merger) that will result in the company becoming privately held and delisted from public markets.","company_name":"LakeShore Biopharma Co., Ltd.","ticker":"LSBWF","filing_date":"2026-06-22","form":"6-K","submitted_at":null,"items":[{"id":9438,"accession_number":"0001213900-26-070363","item_number":"EX-99.1","item_title":"ea029541301ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The press release announces the results of an extraordinary general meeting of shareholders held on June 19, 2026, where shareholders voted to approve a merger agreement between LakeShore Biopharma, Oceanpine Skyline Inc., and Oceanpine Merger Sub Inc. Approximately 92.3% of outstanding shares voted, with 86.2% of votes cast approving the merger. This is a shareholder vote result on a material transaction (merger) that will result in the company becoming privately held and delisted from public markets.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T11:01:18.993498+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9438,"accession_number":"0001213900-26-070363","item_number":"EX-99.1","item_title":"ea029541301ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The press release announces the results of an extraordinary general meeting of shareholders held on June 19, 2026, where shareholders voted to approve a merger agreement between LakeShore Biopharma, Oceanpine Skyline Inc., and Oceanpine Merger Sub Inc. Approximately 92.3% of outstanding shares voted, with 86.2% of votes cast approving the merger. This is a shareholder vote result on a material transaction (merger) that will result in the company becoming privately held and delisted from public markets.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T11:01:18.993498+00:00","company_name":"LakeShore Biopharma Co., Ltd.","ticker":"LSBWF","filing_date":"2026-06-22"}]}